Taketo Okubo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
NTRK2 expression in gastrointestinal stromal tumors with a special emphasis on the clinicopathological and prognostic impacts.
Journal: Scientific reports
Published: June 26, 2023
Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma.
Journal: Technology in cancer research & treatment
Published: December 08, 2022
Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma.
Journal: Discover oncology
Published: March 25, 2022
IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma.
Journal: Discover oncology
Published: October 14, 2021
Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
Journal: Clinical orthopaedics and related research
Published: June 23, 2020
Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
Journal: Journal of orthopaedic surgery (Hong Kong)
Published: June 17, 2020
Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors.
Journal: Scientific reports
Published: April 23, 2020
Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Journal: Clinical orthopaedics and related research
Published: March 30, 2020
Detection of circulating sarcoma tumor cells using a microfluidic chip-type cell sorter.
Journal: Scientific reports
Published: September 24, 2019
Protein Expression Profiles Corresponding to Histological Changes with Denosumab Treatment in Giant Cell Tumors of Bone.
Journal: Proteomics. Clinical applications
Published: September 10, 2018
Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial sarcoma.
Journal: Oncotarget
Published: April 23, 2018
PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.
Journal: Oncotarget
Published: January 30, 2018
Last Updated: 09/26/2026